BA 015 gene therapy

N/A

Report date: 2024/09/26 15:34:02

Base Information

Drug NameBA 015 gene therapy
Drug Alias NamePlasmid AMEPBA-015 AMEP peptideAMEPSynfoldinp-AMEP +[6] 
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionIntegrin alpha-5/beta-1 antagonistsIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-5/beta-1Integrin alpha-V/beta-3
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySloveniaFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValerio Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValerio Therapeutics SA
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A